Related News

8 countries where your Indian driving licence is valid

New Zealand is definitely a road-tripper’s paradise with its rolling hills, turquoise lakes, and the occasional hobbit. The best part? You can drive here for up to a year with

Catalhoyuk: 9,000-year-old city ruled by women, DNA reveals story of matriarchal civilization |

In a recent study published in Science, researchers have uncovered genetic evidence suggesting that Catalhoyuk, one of the oldest and best-preserved Neolithic settlements located in southern Anatolia (modern-day Turkey), was

The psychology behind why we hoard clothes we never wear

Open your closet, and chances are you’ll spot at least a few items you haven’t worn in months, maybe even years. That dress with the tag still on, the jeans

5 Yoga poses that strengthen the heart

This twisting, also known as Seated Spinal Twist, pose massages the internal organs, including the heart, helping to improve circulation. It also helps detoxify the body and relieve tension in

Torrent in Rs 18,000 crore deal, 2nd largest in pharma sector

Word Count: 693 | Estimated Reading Time: 4 minutes

NEW DELHI: Torrent Pharma will acquire a controlling stake in JB Chemicals & Pharmaceuticals (JB Chem) in a deal size of around Rs 18,000 crore, including an open offer. This is the second largest deal in pharma space after Sun Pharma’s $4 billion acquisition of Ranbaxy over a decade back. The deal will create India’s second most valued pharma company (after Sun Pharma), with a revenue of over Rs 15,000 crore, and will be ranked among the top five pharma players. The transaction in the first phase includes Torrent Pharma’s acquisition of 46.4% stake in JB Chem from US PE major KKR for nearly Rs 11,917 crore, which will be followed by an open offer of up to 26% from public shareholders. The equity valuation of JB Chem is Rs 25,689 crore, while its market cap is Rs 28,000 crore.

As per the agreement signed between the two on Sunday, Torrent Pharma is acquiring KKR’s stake in JB Chem at Rs 1,600 per share, while the open offer is at Rs 1,639 per share. The deal price is at nearly 9% discount to JB Chem’s closing price of Rs 1,800 on June 27. KKR’s stake in the company is held through its subsidiary Tau Investment Holdings. In the second phase, Torrent and JB Pharma will be merged through a scheme of arrangement under which every shareholder holding 100 shares in JB Pharma shall receive 51 shares of Torrent. TOI in its June 28 edition had reported the deal value of around Rs 20,000 crore.About five years back, the PE major had acquired 54% in JB Chem from the promoters, the Mody family, for approximately Rs 3,100 crore, or Rs 745 per share. In March this year, KKR divested about 7% stake through block deals. The PE major has been seeking to exit its investment in JB Chem for some time and had initiated the process last year. However, negotiations with the potential bidders were stalled due to valuation concerns.In addition, Torrent is also expected to acquire up to 2.8% of equity shares from certain employees of JB Pharma at Rs 1,600 per share.The deal and merger scheme are subject to standard requisite statutory and regulatory approvals.

Source link